Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement

British Journal of Cancer
L M ButlerP A Cowled

Abstract

Expression of Fas, an apoptosis-inducing receptor, in colonic epithelium is progressively reduced during malignant transformation. We have examined the human Fas gene for loss of heterozygosity (LOH) and gross rearrangements in colon tumours and matched normal mucosa. Polymerase chain reaction (PCR) primers were designed to span a DraI restriction fragment length polymorphic site in the gene. Heterozygosity was detected in normal DNA samples by PCR amplification of the polymorphic site and restriction enzyme digestion. Thirty-eight of 88 patients (43%) with colon carcinomas were informative for the assay, and LOH was detected in 6 of the 38 (16%) corresponding tumours. Tumours from three patients with LOH did not express detectable Fas mRNA, and Fas expression was reduced or absent in 7 of 11 tumours from informative patients without LOH. Southern blotting of tumour DNA samples was used to detect rearrangement of the Fas gene, but no altered hybridization patterns were observed in 64 tumours analysed. These findings indicate that disruption of the Fas gene is not primarily responsible for the loss of Fas protein expression reported in colon cancer. We have also shown that loss of Fas gene transcription is common in these tumour...Continue Reading

Citations

Aug 13, 1999·The American Journal of Physiology·Y Y FanR S Chapkin
Apr 25, 2000·Oncogene·M SchröterE Reichmann
Jun 11, 2011·Pathology Research International·Osamu NunobikiSadamu Noda
Jan 27, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anna TrauzoldHolger Kalthoff
May 22, 2019·International Journal of Molecular Sciences·Nor Isnida IsmailRakesh Naidu
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Hung-Cheng LaiTang-Yuan Chu
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Soroosh RadfarEtienne Hollande
Jun 30, 2007·Journal of Endocrinological Investigation·M ErdoganA G Ozgen
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D RosenG Berke
Mar 22, 2014·Biomedical Reports·Qiaoying HuangYanling Hu
Aug 22, 2018·Oncology Letters·Efthimios DardiotisAlexandros Daponte
Nov 15, 2007·Virchows Archiv : an International Journal of Pathology·Enrique LermaJaime Prat
Mar 30, 1999·Experimental Cell Research·M W McBurney
Dec 17, 2002·Critical Reviews in Oncology/hematology·J J KoornstraJ H Kleibeuker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.